COVID-19 and medicine supply

During the COVID-19 pandemic, our key priority is to safeguard the health of our employees and the continued supply of our lifesaving medicines to patients. Currently we are not experiencing any constraints with our production.  

We are aware that health authorities and pharmacies are doing their best to ensure the availability of insulin for those who need it during the coronavirus pandemic, and we can assure you that our current stock levels are normal. It is important for us that you are informed and reassured. As we continue to monitor the situation, we will share our updates. 

If you have any questions or concerns,  please contact us

Learn more on www.novonordisk.com

Therapy areas

Novo Nordisk is a healthcare company and world leader in diabetes care, with more than 90 years of innovation.

Diabetes care

Haemophilia and bleeding disorders

Growth Hormone therapy

Contact

Novo Nordisk Tunisia Building Al Fajr, 3rd Floor Street Lac Lochness, Les Berges du Lac, Tunisia

Tel : +216 71 656 155
Fax : +216 71 656 073

Medical information :
informed@novonordisk.com

Report a complaint or a side effect

We offer 0 job opportunities

For jobs in the United States, please visit our US career site.